JSNA

Joint Strategic Needs Assessment (JSNA) reports are used by local authorities and NHS commissioners to understand the health, care and wellbeing needs of the local community.

JNSA reports show a snapshot in time. We produce them annually using data extracted from EMIS on 1 April. The reports are published after the April extraction date, once we have analysed the data.

The reports cover the whole NHS North East London region, which includes Barking and Dagenham, City and Hackney, Havering, Newham, Redbridge, Tower Hamlets and Waltham Forest.

JSNA reports 2024

Click a stage to download the report:

Prevalence reporting

Locality reports, with detail at network and practice level. Shows register size, crude prevalence and age standardised prevalence for major disease conditions, including:

Asthma
Atrial Fibrillation
Chronic Kidney Disease
Diabetes
Hypertension
Mental Health (serious mental illness)

See the index (below) for a full list of conditions.

Prevalence reporting

Locality reports, with detail at network and practice level. Shows register size and crude prevalence for conditions, including:

Epilepsy
Learning Disabilities
Multiple Sclerosis
Osteoporosis
Palliative Care
Parkinson's Disease
Rheumatoid Arthritis

See the index (below) for a full list of conditions.

Prevalence reporting

Locality reports, with detail at network and practice level. Shows register size and crude prevalence for diseases and conditions, including:

Cancer
Eating disorders
Homelessness
Housebound
Obesity
Psoriasis
Substance Misuse

See the index (below) for a full list of conditions.

Demographic reporting

At locality level, showing patient counts by register for a wide range of diseases and conditions. Demographic information:

Age band (10-year)
Ethnic group recording (5 ethnic categories)
Sex / gender
Deprivation – quintiles using IMD score (Index of Multiple Deprivations)

Demographic reporting

At locality level, showing patient counts by register for Coronary Heart Disease, Diabetes, and Stroke. Each with sub-populations for current smokers, blood pressure level, and blood indicator level (e.g. cholesterol, HbA1c). Demographic information:

Age band (10-year)
Ethnic group recording
Sex / gender
Deprivation – quintiles using IMD score (Index of Multiple Deprivations)

Quick reference index

These are all of the conditions covered by the JSNA, and the stage reports that contain information about them:

Asthma 1a, 2
Atrial Fibrillation 1a
Cancer 1c
Chronic Kidney Disease (CKD) 1a
Chronic Obstructive Pulmonary Disease (COPD) 1a, 2
Coronary Heart Disease (CHD) 1a, 2, 3
Current Smoker 2
Dementia 1a, 2
Depression 1a
Diabetes 1a, 2, 3
Diabetes - Type 1 2
Diabetic Retinal Screening 1b
Eating disorders 1c
Epilepsy 1b, 2
Heart Failure 1a
Homelessness 1c
Housebound 1c
Human Immunodeficiency Virus (HIV) 1b
Hypertension 1a, 2
Learning Disabilities 1b, 2
Mental Health 1a
Motor Neurone Disease 1b, 2
Multiple Sclerosis 2
Obesity 1c, 2
Osteoporosis 1b
Palliative Care 1b
Parkinson's Disease 1b, 2
Peripheral Arterial Disease (PAD) 1a, 2
Psoriasis 1c
Rheumatoid Arthritis 1b
Severe Mental Illness (SMI) 2
Stroke / Transient Ischaemic Attack 1a, 2, 3
Substance Misuse 1c

2023

JSNA 2023 stage 1a [XLS 216KB]

Includes register size, crude prevalence and age standardised prevalence, broken down by locality and individual practice for:

Asthma, atrial fibrillation, coronary heart disease, chronic kidney disease, chronic obstructive pulmonary disease, dementia, depression, diabetes, heart failure, hypertension, peripheral arterial disease, serious mental illness (mental health), stroke.

JSNA 2023 stage 1b [XLS 158KB]

Includes register size and crude prevalence, broken down by locality and individual practice for:

Diabetes – retinal screening, eating disorders, epilepsy, HIV, homelessness, learning disabilities, motor neurone disease, multiple sclerosis, osteoporosis, palliative care, Parkinson's Disease, psoriasis, rheumatoid arthritis, substance misuse.

JSNA 2023 stage 2 [XLS 4,357KB]

Includes register size by sex, age, deprivation quintile, ethnicity, and the presence of specific further conditions, broken down by locality for:

Asthma, coronary heart disease, stroke, learning disabilities, obesity, diabetes, hypertension, chronic obstructive pulmonary disease, serious mental illness (mental health), current smokers, epilepsy, multiple sclerosis, Parkinson's disease, diabetes - type 1, dementia, peripheral arterial disease.

JSNA 2023 stage 3 [XLS 10,019KB]

Includes number of patients meeting the different process measures for each condition, reported by sex, age, deprivation quintile, ethnicity, and the presence of specific further conditions. Broken down by locality for:

Diabetes patients who are current smokers, or who have controlled cholesterol / blood pressure / blood sugar (HbA1c), or retinal screening done. Stroke patients who are current smokers, or who have controlled cholesterol / blood pressure. Coronary heart disease patients who are current smokers, or who have controlled cholesterol / blood pressure.

2022

JSNA 2022 - Stage 1a [XLS 218KB]

Includes register size, crude prevalence and age standardised prevalence, broken down by locality and individual practice for:

Active asthma, atrial fibrillation, coronary heart disease, chronic kidney disease, chronic obstructive pulmonary disease, dementia, depression, diabetes, heart failure, hypertension, peripheral arterial disease, serious mental illness, stroke.

JSNA 2022 - Stage 1b [XLS 136KB]

Includes register size, crude prevalence and age standardised prevalence, broken down by locality and individual practice for:

Diabetes – retinal screening, epilepsy, HIV, learning disabilities, multiple sclerosis, osteoporosis, palliative care, Parkinson’s disease, rheumatoid arthritis.

JSNA 2022 - stage 2 [XLS 7,799KB]

Includes register size, crude prevalence and age standardised prevalence, broken down by locality and individual practice for:

Active asthma, chronic obstructive pulmonary disease, coronary heart disease, dementia, diabetes (age 17+), diabetes type 1 (all ages), epilepsy, hypertension, learning disabilities, multiple sclerosis, obesity, Parkinson’s disease, peripheral arterial disease, serious mental illness, smokers, stroke/TIA.